PEPT Among Its Peers
End-of-day Nov 20, 2026 · 0 ETFs by YTD
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −1.9% | −8.1% | −1.4% | — | — | — | — | — | — | +3.1% |
| S&P 500 · VOO | −3.4% | −8.3% | −9.5% | −9.2% | +2.2% | +5.5% | +59.8% | +58.7% | +275.8% | — |
$135 of every $1,000 in PEPT is Eli
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | LLYELI Lilly | Healthcare | 13.48% | $1,347.77 | 315 | $426K |
| 2 | ASNDAscendis Pharma A/S | Healthcare | 11.07% | $1,107.22 | 1,366 | $350K |
| 3 | NVONovo Nordisk A/S | Healthcare | 9.99% | $999.01 | 8,116 | $315K |
| 4 | PODDInsulet | Healthcare | 7.64% | $763.98 | 1,758 | $241K |
| 5 | RYTMRhythm Pharmaceuticals | Healthcare | 6.24% | $623.61 | 1,686 | $197K |
| 6 | PTGXProtagonist Therapeutics | Healthcare | 6.13% | $612.67 | 1,560 | $193K |
| 7 | SANSanofi | Financial Services | 5.87% | $587.17 | 2,015 | $185K |
| 8 | DARDarling Ingredients | Consumer Defensive | 4.03% | $403.36 | 2,449 | $127K |
| 9 | —Bachem | — | 3.68% | $367.68 | 1,228 | $116K |
| 10 | VKTXViking Therapeutics | Healthcare | 3.66% | $366.02 | 4,473 | $116K |
| 11 | —Ipsen | — | 3.04% | $303.85 | 538 | $96K |
| 12 | PBLSParabilis Medicines | Healthcare | 2.68% | $268.22 | 3,066 | $85K |
| 13 | ZEALZealand Pharma A/S | — | 2.47% | $247.12 | 2,497 | $78K |
| 14 | AUPHAurinia Pharmaceuticals | Healthcare | 2.20% | $220.30 | 4,672 | $70K |
| 15 | MBXMBX Biosciences | Healthcare | 2.04% | $204.32 | 1,208 | $65K |
PEPT has no close peers in our data yet: […]
Not enough history yet: PEPT needs a year of prices.
PEPT does not pay a distribution.
Official documents are being connected from SEC EDGAR: […]. Read the issuer’s prospectus before investing.
Estimated yearly cost excludes trading costs and assumes constant assets.
No payouts on record: […]
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | LLY | ELI Lilly & | 13.48% |
| 2 | ASND | Ascendis Pharma A/S | 11.07% |
| 3 | NVO | Novo Nordisk A/S | 9.99% |
| 4 | PODD | Insulet | 7.64% |
| 5 | RYTM | Rhythm Pharmaceuticals | 6.24% |
| 6 | PTGX | Protagonist Therapeutics | 6.13% |
| 7 | SAN | Sanofi | 5.87% |
| 8 | DAR | Darling Ingredients | 4.03% |
| 9 | VKTX | Viking Therapeutics | 3.66% |
| 10 | PBLS | Parabilis Medicines | 2.68% |